Matches in Wikidata for { <http://www.wikidata.org/entity/Q61660699> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- Q61660699 description "article scientifique publié en 2014" @default.
- Q61660699 description "im September 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61660699 description "wetenschappelijk artikel" @default.
- Q61660699 description "наукова стаття, опублікована у вересні 2014" @default.
- Q61660699 name "Abstract 4747: Design and synthesis of a series highly potent and bioavailable FASN KR domain inhibitors for cancer" @default.
- Q61660699 name "Abstract 4747: Design and synthesis of a series highly potent and bioavailable FASN KR domain inhibitors for cancer" @default.
- Q61660699 type Item @default.
- Q61660699 label "Abstract 4747: Design and synthesis of a series highly potent and bioavailable FASN KR domain inhibitors for cancer" @default.
- Q61660699 label "Abstract 4747: Design and synthesis of a series highly potent and bioavailable FASN KR domain inhibitors for cancer" @default.
- Q61660699 prefLabel "Abstract 4747: Design and synthesis of a series highly potent and bioavailable FASN KR domain inhibitors for cancer" @default.
- Q61660699 prefLabel "Abstract 4747: Design and synthesis of a series highly potent and bioavailable FASN KR domain inhibitors for cancer" @default.
- Q61660699 P1433 Q61660699-C9439437-023E-4158-B4CE-42C6A2C80793 @default.
- Q61660699 P1476 Q61660699-06DA3452-E0B3-4AD8-9B02-F741A6221C51 @default.
- Q61660699 P2093 Q61660699-00BE8B23-7BD5-4038-A06D-C6B28372AB39 @default.
- Q61660699 P2093 Q61660699-09E4E4D0-77AA-4393-905E-5133E5A059D0 @default.
- Q61660699 P2093 Q61660699-0F4106EA-FA68-4B06-BF8F-A92BA03501B8 @default.
- Q61660699 P2093 Q61660699-103EACE8-5829-4052-AB0C-D29950CC77B7 @default.
- Q61660699 P2093 Q61660699-10B13EEC-E1CB-4D16-BBBA-690E4375A9DC @default.
- Q61660699 P2093 Q61660699-2697412C-96A8-4755-804D-D3B9BD6A14FF @default.
- Q61660699 P2093 Q61660699-2F436251-EE57-4B18-8AE5-D5C063CC9893 @default.
- Q61660699 P2093 Q61660699-4C15CBC3-8FA1-4E68-B3EC-8B5292761735 @default.
- Q61660699 P2093 Q61660699-54AFCF6F-5037-4879-BE64-A8366997AEB2 @default.
- Q61660699 P2093 Q61660699-569B5291-4598-4FE8-A527-EA0EAB09A0FC @default.
- Q61660699 P2093 Q61660699-6B366F4D-C18B-4C76-9CF3-FA4A28828CA0 @default.
- Q61660699 P2093 Q61660699-8E305939-FD0B-450F-94F7-BB85CBAAF576 @default.
- Q61660699 P2093 Q61660699-A5E25504-D9D0-4F77-8003-C2563600EAA5 @default.
- Q61660699 P2093 Q61660699-A5F31F7E-24B6-4C37-969C-A7ED155D7DFC @default.
- Q61660699 P2093 Q61660699-CA915E96-7A4B-4000-8092-AE2E6AED87CB @default.
- Q61660699 P2093 Q61660699-DC99BDE3-2220-458D-9A7C-8982B5C9175C @default.
- Q61660699 P2093 Q61660699-DD8E0174-77F1-41C2-94C0-4DD207E690A7 @default.
- Q61660699 P2093 Q61660699-ED18D36B-BBB2-41FB-90A5-D4E1865DC2CF @default.
- Q61660699 P2093 Q61660699-F7980854-3087-496D-B781-9D3BC3626A19 @default.
- Q61660699 P2093 Q61660699-FF7697CE-3092-436D-99D1-D004449E8171 @default.
- Q61660699 P304 Q61660699-6112AFF7-955A-4A79-907F-9107F367BC88 @default.
- Q61660699 P31 Q61660699-671534E5-DAF2-4AA6-95B7-18CFD03175E9 @default.
- Q61660699 P356 Q61660699-DD9E02CD-B360-4D77-8C2F-AC83778DCC9B @default.
- Q61660699 P407 Q61660699-EA958B6E-B546-401B-BA13-A9D24AB50096 @default.
- Q61660699 P433 Q61660699-DD935315-FFEB-4DCA-9C41-0DB8924FBA42 @default.
- Q61660699 P478 Q61660699-559A4519-0B89-4E22-8922-23E682BC445A @default.
- Q61660699 P50 Q61660699-8A751F11-A0C6-42C1-8701-CFE38A1AD9FB @default.
- Q61660699 P577 Q61660699-7A448CBD-7709-45BE-8B9C-A6A0E180F80C @default.
- Q61660699 P356 1538-7445.AM2014-4747 @default.
- Q61660699 P1433 Q326097 @default.
- Q61660699 P1476 "Abstract 4747: Design and synthesis of a series highly potent and bioavailable FASN KR domain inhibitors for cancer" @default.
- Q61660699 P2093 "Boudewijn Janssens" @default.
- Q61660699 P2093 "Bruce Grasberger" @default.
- Q61660699 P2093 "Carsten Schubert" @default.
- Q61660699 P2093 "Christophe Meyer" @default.
- Q61660699 P2093 "Danielle Peeters" @default.
- Q61660699 P2093 "Donald Ludovici" @default.
- Q61660699 P2093 "Erwin Fraiponts" @default.
- Q61660699 P2093 "Gilles Bignan" @default.
- Q61660699 P2093 "James Bischoff" @default.
- Q61660699 P2093 "Karine Smans" @default.
- Q61660699 P2093 "Lieven Meerpoel" @default.
- Q61660699 P2093 "Luc Van Nuffel" @default.
- Q61660699 P2093 "Max Cummings" @default.
- Q61660699 P2093 "Norbert Esser" @default.
- Q61660699 P2093 "Peter Connolly" @default.
- Q61660699 P2093 "Peter Vermeulen" @default.
- Q61660699 P2093 "Richard Alexander" @default.
- Q61660699 P2093 "Ron Gilissen" @default.
- Q61660699 P2093 "Sabine De Breucker" @default.
- Q61660699 P2093 "Tianbao Lu" @default.
- Q61660699 P304 "4747-4747" @default.
- Q61660699 P31 Q13442814 @default.
- Q61660699 P356 "10.1158/1538-7445.AM2014-4747" @default.
- Q61660699 P407 Q1860 @default.
- Q61660699 P433 "19 Supplement" @default.
- Q61660699 P478 "74" @default.
- Q61660699 P50 Q56591120 @default.
- Q61660699 P577 "2014-09-30T00:00:00Z" @default.